Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/7237
Title: | Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement | Authors: | Vrdoljak, Eduard Bodoky, Gyorgy Jassem, Jacek Popescu, Razvan A Mardiak, Jozef Pirker, Robert Čufer, Tanja Bešlija, Semir Eniu, Alexandru Todorović, Vladimir Kubáčková, Kateřina Kurteva, Galia Tomašević, Zorica Sallaku, Agim Smichkoska, Snezhana Bajić, Žarko Šikić, Branimir I |
Issue Date: | 2016 | Publisher: | Alphamed Press | Journal: | The Oncologist | Abstract: | : The incidence of many cancers is higher in Western European (WE) countries, but mortality is frequently higher in Central and Eastern European (CEE) countries. A panel of oncology leaders from CEE countries participating in the South Eastern European Research Oncology Group (SEEROG) was formed in 2015, aiming to analyze the current status and trends of oncology care in CEE and to propose recommendations leading to improved care and outcomes. The SEEROG panel, meeting during the 11th Central European Oncology Congress, proposed the following: (a) national cancer control plans (NCCPs) required in all CEE countries, defining priorities in cancer care, including finance allocation considering limited health care budgets; (b) national cancer registries, describing in detail epidemiological trends; (c) efforts to strengthen comprehensive cancer centers; (d) that multidisciplinary care should be mandated by the NCCPs; (e) that smaller hospitals should be connected to multidisciplinary tumor boards via the Internet, providing access to specialized expertise; (f) nationwide primary prevention programs targeting smoking, obesity, and alcohol consumption and centrally evaluated secondary prevention programs for cervical, colorectal, and breast cancers; (g) prioritize education for all involved in cancer care, including oncology nurses, general practitioners, and palliative care providers; (h) establish outpatient care in day hospitals to reduce costs associated with the current inpatient model of care in CEE countries and to improve patients' quality of life; (i) long-term pharmacoeconomic evaluations of new therapies in CEE countries; (j) increase national oncology budgets in view of the higher mortality rates in CEE compared with WE countries; and (k) CEE countries urgently need help from the European Union to increase and monitor overall investment in cancer care. | URI: | http://hdl.handle.net/20.500.12188/7237 | DOI: | 10.1634/theoncologist.2016-0137 |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.